Joplin Globe8d
Atalanta Therapeutics Closes Oversubscribed $97 Million Series B Financing to Advance Two RNAi Therapies for CNS Diseases to Clinical Trials
Atalanta Therapeutics, a biotechnology company pioneering RNA interference (RNAi) for the treatment of neurological diseases, today announced the completion of a $97 million Series B financing to ...
Grand Rapids Herald-Review15d
Memphis man recounts teenage days aiding worker’s strike during King’s last visit to the city
At the National Civil Rights Museum at the Lorraine Motel in Memphis one September day, tourists pause solemnly before a ...